---
schema_version: "secwatch.filing_event.v1"
accession: "0001906324-24-000025"
form_type: "8-K"
ticker: "QDEL"
cik: "0001906324"
company_name: "QuidelOrtho Corp"
filed_at: "2024-05-07T23:59:59+00:00"
generated_at: "2026-06-02T20:57:53.284021+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# QuidelOrtho appoints Brian J. Blaser as CEO effective May 6, 2024

## Summary
- Blaser, ex-Abbott EVP Diagnostic Products, replaces interim CEO Michael Iskra and interim President Robert Bujarski.
- He receives $1M base salary, annual target cash bonus of 125% of base, and equity grants totaling $10M.
- Board expanded to 11 members; Blaser joins as director effective May 15, 2024.
- Interim Office of the CEO dissolved; Iskra and Bujarski return to prior executive roles.

## SEC filing metadata
- accession: 0001906324-24-000025
- form_type: 8-K
- ticker: QDEL
- cik: 0001906324
- company_name: QuidelOrtho Corp
- filed_at: 2024-05-07T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1906324/000190632424000025/0001906324-24-000025-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1906324/000190632424000025/qdel-20240501.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001906324-24-000025
- JSON: https://secwatch.observer/filing/0001906324-24-000025.json
- Plain text: https://secwatch.observer/filing/0001906324-24-000025.txt

## Key facts
- Executive change
  Brian J. Blaser was appointed as President and Chief Executive Officer at QuidelOrtho Corp.
  - Action: appointed
  - Role: President and Chief Executive Officer
  source text: The Board of Directors (the “Board”) of QuidelOrtho Corporation (the “Company”) has appointed Brian J. Blaser to serve as the Company’s President and Chief Executive Officer, effective as of May 6, 2024 (the “Effective Date”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1906324/000190632424000025/0001906324-24-000025-index.htm
- Executive change
  Robert J. Bujarski changed role as Interim President at QuidelOrtho Corp.
  - Action: stepped down
  - Role: Interim President
  source text: each of Michael S. Iskra, who served as the Company’s Interim Chief Executive Officer, and Robert J. Bujarski, who served as the Company’s Interim President, stepped down from these interim positions.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1906324/000190632424000025/0001906324-24-000025-index.htm
- Executive change
  Brian J. Blaser was appointed as director at QuidelOrtho Corp.
  - Action: appointed
  - Role: director
  source text: In addition, effective as of May 15, 2024, the Board expanded its size from ten to eleven directors and appointed Mr. Blaser to serve as a director until the Company’s 2025 Annual Meeting of Stockholders.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1906324/000190632424000025/0001906324-24-000025-index.htm
- Executive change
  Michael S. Iskra changed role as Interim Chief Executive Officer at QuidelOrtho Corp.
  - Action: stepped down
  - Role: Interim Chief Executive Officer
  source text: each of Michael S. Iskra, who served as the Company’s Interim Chief Executive Officer, and Robert J. Bujarski, who served as the Company’s Interim President, stepped down from these interim positions.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1906324/000190632424000025/0001906324-24-000025-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.